Researchers have launched a new telehealth platform called Niagen Plus, allowing eligible patients to receive prescription-only NAD+ therapy directly at home. This service combines remote consultations with healthcare professionals and at-home injection kits containing pharmaceutical-grade nicotinamide riboside chloride, a compound linked to longevity. This shift from traditional clinic-based treatments to a more accessible model reflects changing expectations around health interventions and aims to make NAD+ therapy more widely available.

For those interested in aging well, this development could mean easier access to a therapy that may support cellular health and energy production. NAD+ levels decline with age, and maintaining them is thought to be beneficial for metabolism and overall vitality. The Niagen Plus platform offers a new way for people to potentially enhance their healthspan from the comfort of their homes, with the oversight of qualified clinicians ensuring safety and appropriate dosing.

The Niagen Plus platform is still in its early stages, relying on a combination of established biological understanding and ongoing research into its clinical benefits. While the injectable formulation has been well tolerated in clinical trials, the broader impact on significant health outcomes remains under investigation. This means that while the convenience of at-home delivery is appealing, the scientific backing for its effectiveness is still developing.

If you’re considering NAD+ therapy, it’s essential to consult with a healthcare provider to determine if this treatment is appropriate for you. While the telehealth model offers a new level of access, the evidence supporting its long-term benefits is still emerging, so staying informed about ongoing research is crucial.

Source: longevity.technology